Critical Care Lifeline: Why the Rising Incidence of AKI and Sepsis is Rapidly Expanding the India Continuous Renal Replacement Therapy Market.
The India Continuous Renal Replacement Therapy (CRRT) Market is experiencing robust growth, primarily propelled by the alarming increase in acute kidney injury (AKI) incidence among critically ill patients. AKI, often a complication of severe sepsis, major surgery, or multi-organ dysfunction syndrome (MODS), carries high mortality rates, particularly in the intensive care unit (ICU) setting.
Unlike traditional intermittent hemodialysis (IHD), CRRT provides gentle, continuous blood purification over 24 hours, making it the preferred therapeutic modality for hemodynamically unstable patients who cannot tolerate the rapid fluid and solute shifts associated with IHD. This clinical superiority in the most precarious patient population—the elderly, those with severe heart failure, or those in septic shock—establishes CRRT as an essential, life-saving intervention.
The increasing sophistication of Indian critical care units, which are now better equipped to handle complex cases, further drives the demand for dedicated CRRT machines and specialized consumables. As India's medical infrastructure continues its rapid modernization, the focus on better clinical outcomes and improved survival rates in the ICU directly translates into greater adoption of CRRT protocols.